The podcast discusses the impact of weight loss drugs on companies like Weight Watchers and Herbalife. It delves into financial challenges, subscriber losses, and the influence of GLP1s. The podcast also explores the role of Oprah Winfrey in these scenarios and the proactive creditor organization in distressed companies.
Herbalife faces challenges from GLP-1 drugs, investor meetings, and refinance concerns.
Deep dives
Effects of GLP-1 Drugs on Weight Watchers and Oprah Winfrey
The popularity of GLP-1 drugs like Ozempic and Wigovi has impacted Weight Watchers negatively, leading to subscriber losses, amplified by Oprah Winfrey's departure from the Weight Watchers board. This situation prompted Weight Watchers' lenders to engage a law firm to prepare for talks, causing a 13% stock increase. Weight Watchers is exploring options to improve leverage ratio and considering capital structure changes, with bonds quoted in the 40s.
Challenges Faced by Herbalife in Light of GLP-1 Drug Use
Herbalife faces challenges due to the rise of GLP-1 drugs affecting demand for weight loss shakes, integral to their business model. The company previously settled a lawsuit and is now meeting with investors to address upcoming debt maturities. Herbalife is navigating a potential refinance situation amidst concerns regarding their business structure as a multi-level marketing scheme.
Broader Economic Impact of GLP-1 Drugs and Uncertainties
The podcast discusses the broader repercussions of GLP-1 drugs on various industries, including travel, healthcare, and consumer behavior. It highlights the uncertainties surrounding the long-term effects of these drugs on the economy, emphasizing the need for wider availability and insurance coverage. The potential decline in obesity rates could impact healthcare companies reliant on treatments for diabetes and obesity-related issues.
The Ozempic effect is coming for more than just your wardrobe!
Last week, 9finreported that a group of lenders to Weight Watchers parent WW International organized with law firm Gibson Dunn as the company loses subscribers to weight loss drugs.
On a somewhat related note, 9fin also reported that Herbalife is facing challenges of its own after a bad set of earnings. What use are health shakes when you can take a pill to slim down?
Listen as our US deputy distressed editor Rachel Butt and senior reporter William Hoffman talk about these stories, and how Oprah Winfrey is at the center of it all.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode